Healthcare & Life Sciences News and Articles

Google News – Clinical Trials External News

AbbVie eyes extended Qulipta use case on Phase III menstrual migraine win - Clinical Trials Arena

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

AIAI: Proprietary AI identifies key subgroups in clinical trials, boosting success and market potential - TradingView

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

SER: SER-252 advances in clinical trials, targeting unmet needs in advanced Parkinson's with a novel delivery system - TradingView

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

Two patients start a trial for a genetic kidney disease with no FDA-approved therapy for its cause - Stock Titan

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

Biohaven’s epilepsy drug hit with FDA clinical hold - Clinical Trials Arena

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

TenNor reports top-line Phase IIa results for rifaquizinone in PJI - Clinical Trials Arena

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

First healthy volunteers dosed in Bionyra’s Phase I BYN-001 study - Clinical Trials Arena

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy - Fierce Pharma

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

Headlands Research Opens Grand Rapids Site Led by Rheumatology Investigator - The Clinical Trial Vanguard

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer - The Clinical Trial Vanguard

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

Velocity Clinical, Stitch expand partnership across 70+ sites to boost screening attendance - The Clinical Trial Vanguard

news.google.com · 11 Sep 2026

Google News – Clinical Trials External News

Phase 3 study shows aQIVc superior to comparators in older adults - The Clinical Trial Vanguard

news.google.com · 11 Sep 2026

Google News – Pharmaceuticals External News

JCR Pharmaceuticals and Medipal dose first patient in global Phase I/II trial of JR-446 for Sanfilippo syndrome type B - Dealroom

news.google.com · 11 Sep 2026

Google News – Biopharma External News

iX Biopharma’s US$41 mil lifeline a mere droplet in the gushing US military industrial complex - The Edge Singapore

news.google.com · 11 Sep 2026

Google News – Biopharma External News

GC Biopharma wins approval for phase 2 Covid-19 mRNA vaccine trial - Korea Biomedical Review

news.google.com · 11 Sep 2026

News & Articles

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Build the Bench: Internal Mobility for Healthcare’s Hard-to-Fill Work

The Access Architect: A New Clinical Research Workforce Priority

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

For women in the workforce, can AI be the ‘great equalizer’?

What building fair hiring under real regulation taught us, and why the U.S. is next

Inside L’Oréal’s hiring strategy behind 2 million applications a year

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

AbbVie eyes extended Qulipta use case on Phase III menstrual migraine win - Clinical Trials Arena

AIAI: Proprietary AI identifies key subgroups in clinical trials, boosting success and market potential - TradingView

SER: SER-252 advances in clinical trials, targeting unmet needs in advanced Parkinson's with a novel delivery system - TradingView

Two patients start a trial for a genetic kidney disease with no FDA-approved therapy for its cause - Stock Titan

Biohaven’s epilepsy drug hit with FDA clinical hold - Clinical Trials Arena

TenNor reports top-line Phase IIa results for rifaquizinone in PJI - Clinical Trials Arena

First healthy volunteers dosed in Bionyra’s Phase I BYN-001 study - Clinical Trials Arena

In first interview as FDA oncology chief, Angelo de Claro vows to ‘continue the innovation’ behind OCE legacy - Fierce Pharma

Headlands Research Opens Grand Rapids Site Led by Rheumatology Investigator - The Clinical Trial Vanguard

FDA Clears Prelude’s PRT13722 Phase 1 Trial in HR-Positive Breast Cancer - The Clinical Trial Vanguard

Velocity Clinical, Stitch expand partnership across 70+ sites to boost screening attendance - The Clinical Trial Vanguard

Phase 3 study shows aQIVc superior to comparators in older adults - The Clinical Trial Vanguard

JCR Pharmaceuticals and Medipal dose first patient in global Phase I/II trial of JR-446 for Sanfilippo syndrome type B - Dealroom

iX Biopharma’s US$41 mil lifeline a mere droplet in the gushing US military industrial complex - The Edge Singapore

GC Biopharma wins approval for phase 2 Covid-19 mRNA vaccine trial - Korea Biomedical Review